Evaluating Nine-Year Sustainability After Implementing Evidence-Based Practices to Prevent Urinary Tract Infections and Overfilling of the Bladder in Patients With Hip Fracture

March 24, 2026 updated by: maria frödin, Sahlgrenska University Hospital

Nine-Year Sustainability After Implementing Measures to Prevent Catheter- Associated Urinary Tract Infections and Bladder Distension in Patients With Hip Fracture

This study focuses on evaluating the long-term sustainability of a urinary catheter care bundle designed to prevent urinary tract infections and bladder distension in patients undergoing surgery for hip fractures. The intervention, which included two key innovations-a urinary catheter certificate and a nurse-driven urinary catheter protocol, was implemented between 2015 and 2020 and successfully reduced urinary tract infections and bladder distension, previously published. However, due to the pandemic, the initiative was paused and had to be reintroduced in 2022. Now, the study aims to assess the effectiveness of these preventive measures 9 years after their initial implementation. The research will analyze changes in the incidence of urinary tract infections, bladder distension, catheterisation methods, and documentation practices in patients aged 65 and older. The findings will help inform healthcare policies and may have broader implications for preventing adverse events in other surgical patient groups

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

750

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Sweden
    • Västra Götaland County
      • Mölndal, Västra Götaland County, Sweden, 43180
        • Sahlgrenska Academy, Sahlgrenska University hospital/Mölndal

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients aged 65 years and older undergoing hip fracture surgery at a university hospital in Sweden.

Description

Inclusion Criteria:

-Hip fracture surgery at the study site, age 65 years and older and cared for in the ortho-geriatric wards.

Exclusion Criteria:

-No catheterisation during hospital stay

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients undergoing hip fracture surgery year nine after the intervention started.
Behavioral: Safe Hands and Safe Bladder intervention
Evaluating changes in urinary tract infections and bladder distension nine-year after implementing preventive measures

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Describe changes in the incidence of in-hospital urinary catheter-associated infections; Year 9 will be compared with previously published data from Years 1-5
Time Frame: For one year

Definition: Urinary tract infection with onset on day 3 after admission with prior urinary catheterisation. A physician prescribed antimicrobial agents for a urinary tract infection during the hospital stay. Data will be collected from patients' medical records.

Logistic regression analysis will be performed
For one year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in the incidence of in-hospital acquired bladder distension will be compared; Year 9 will be compared to previously published data from Years 1-5.
Time Frame: For one year.
Definition: Bladder distension is defined according to the national marker for point prevalence measurement when assessing adverse events. Bladderscan volume from patients' medical records.
For one year.
Changes in urine volume of 500ml and more during hospital stay. Year nine will be compared yera 1-5, previous published data
Time Frame: For one year
Bladderscan volume from patients' medical records.
For one year
Changes in catheterization methods during the hospital stay will be compared, with data from Year 9 compared to previously published data from Years 1-5
Time Frame: For one year
Data will be collected from patients' medical records.
For one year
Changes in urinary catheter-related documentation in Year 9 will be compared to previously published data from Years 1-5.
Time Frame: For one year
Catheter-related documentation will be collected from patients' medical records.
For one year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sahlgrenska University Hospital

Investigators

  • Principal Investigator: Annette Erichsen, Associate Professor, Gothenburg University, Sahlgrenska University Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 5, 2025

Primary Completion (Actual)

October 30, 2025

Study Completion (Actual)

October 30, 2025

Study Registration Dates

First Submitted

March 11, 2025

First Submitted That Met QC Criteria

March 22, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2026

Last Update Submitted That Met QC Criteria

March 24, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2025-00397-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe